Short duration combination chemotherapy in the treatment of small cell lung cancer.
Ninety five patients (57 with limited disease and 38 with extensive disease) with previously untreated small cell lung cancer were entered into a study of short duration combination chemotherapy with intravenous cyclophosphamide (750 mg/m2) on day 1, adriamycin (40 mg/m2) on day 1, and etoposide VP-...
Gardado en:
| Publicado en: | Thorax |
|---|---|
| Principais autores: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
1986
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC460432/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3024351/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.41.9.688 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
